NVAX NOVAVAX INC revenue, earnings and financials
For the quarter ended June 30, 2026, NOVAVAX INC reported revenue of $56.7M (down 76.3% from a year earlier), net income of −$53.4M and diluted EPS of −$0.32; over the last four quarters revenue was $414M and net income −$248M; for the fiscal year ended December 2025 revenue was $1.12B, up 64.7% on the year before.
NVAX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.12B, gross profit n/a, operating income $453M, net income $440M (margin 39.2%), EPS $2.58
- Fiscal year ended Dec 2024: revenue $682M, gross profit n/a, operating income −$249M, net income −$187M (margin -27.5%), EPS −$1.23
- Fiscal year ended Dec 2023: revenue $984M, gross profit n/a, operating income −$567M, net income −$545M (margin -55.4%), EPS −$5.41
- Fiscal year ended Dec 2022: revenue $1.98B, gross profit n/a, operating income −$645M, net income −$658M (margin -33.2%), EPS −$8.42
- Fiscal year ended Dec 2021: revenue $1.15B, gross profit n/a, operating income −$1.69B, net income −$1.74B (margin -152.1%), EPS −$23.44
NVAX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $56.7M (down 76.3% year over year), net income −$53.4M, EPS −$0.32
- Quarter ended Mar 31, 2026: revenue $140M (down 79.1% year over year), net income −$9.49M, EPS −$0.06
- Quarter ended Dec 31, 2025 (from the annual report): revenue $147M (up 66.6% year over year), net income $17.5M, EPS $0.28
- Quarter ended Sep 30, 2025: revenue $70.4M (down 16.6% year over year), net income −$202M, EPS −$1.25
- Quarter ended Jun 30, 2025: revenue $239M (down 42.4% year over year), net income $107M, EPS $0.62
- Quarter ended Mar 31, 2025: revenue $667M (up 610.3% year over year), net income $519M, EPS $2.93
- Quarter ended Dec 31, 2024 (from the annual report): revenue $88.3M (down 69.7% year over year), net income −$81.0M, EPS −$0.41
- Quarter ended Sep 30, 2024: revenue $84.5M (down 54.8% year over year), net income −$121M, EPS −$0.76
- Quarter ended Jun 30, 2024: revenue $415M (down 2.1% year over year), net income $162M, EPS $0.99
- Quarter ended Mar 31, 2024: revenue $93.9M (up 15.9% year over year), net income −$148M, EPS −$1.05
- Quarter ended Dec 31, 2023 (from the annual report): revenue $291M (down 18.5% year over year), net income −$178M, EPS −$1.32
- Quarter ended Sep 30, 2023: revenue $187M (down 74.5% year over year), net income −$131M, EPS −$1.26
- Quarter ended Jun 30, 2023: revenue $424M (up 128.3% year over year), net income $58.0M, EPS $0.58
- Quarter ended Mar 31, 2023: revenue $81.0M (down 88.5% year over year), net income −$294M, EPS −$3.41
- Quarter ended Dec 31, 2022 (from the annual report): revenue $357M (up 60.8% year over year), net income −$182M, EPS −$2.30
- Quarter ended Sep 30, 2022: revenue $735M (up 310.7% year over year), net income −$169M, EPS −$2.15
- Quarter ended Jun 30, 2022: revenue $186M (down 37.6% year over year), net income −$510M, EPS −$6.53
- Quarter ended Mar 31, 2022: revenue $704M (up 57.4% year over year), net income $203M, EPS $2.56
- Quarter ended Dec 31, 2021 (from the annual report): revenue $222M, net income −$846M, EPS −$11.33
- Quarter ended Sep 30, 2021: revenue $179M, net income −$322M, EPS −$4.31
NVAX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$245M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$87.3M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$714M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$416M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $323M, share buybacks n/a
NVAX balance sheet
- Jun 30, 2026: cash $191M, total assets $956M, total liabilities $1.15B, shareholders' equity −$191M
- Mar 31, 2026: cash $228M, total assets $1.04B, total liabilities $1.19B, shareholders' equity −$145M
- Dec 31, 2025: cash $241M, total assets $1.18B, total liabilities $1.30B, shareholders' equity −$128M
- Sep 30, 2025: cash $268M, total assets $1.18B, total liabilities $1.34B, shareholders' equity −$157M
- Jun 30, 2025: cash $254M, total assets $1.34B, total liabilities $1.30B, shareholders' equity $37.6M
- Mar 31, 2025: cash $263M, total assets $1.29B, total liabilities $1.37B, shareholders' equity −$75.6M
- Dec 31, 2024: cash $530M, total assets $1.56B, total liabilities $2.18B, shareholders' equity −$624M
- Sep 30, 2024: cash $574M, total assets $1.71B, total liabilities $2.24B, shareholders' equity −$526M
What is NVAX's revenue?
NOVAVAX INC reported $414M of revenue over its last four quarters, through June 30, 2026.
Is NVAX profitable?
No. NOVAVAX INC lost $248M over the last four quarters.
What is NVAX's EPS?
Diluted earnings per share over the last four quarters were −$1.35; −$0.32 in the latest quarter.